190 related articles for article (PubMed ID: 20547493)
1. Genetic variation in the progesterone receptor gene and risk of endometrial cancer: a haplotype-based approach.
Lee E; Hsu C; Haiman CA; Razavi P; Horn-Ross PL; Van Den Berg D; Bernstein L; Le Marchand L; Henderson BE; Setiawan VW; Ursin G
Carcinogenesis; 2010 Aug; 31(8):1392-9. PubMed ID: 20547493
[TBL] [Abstract][Full Text] [Related]
2. Clarifying the PROGINS allele association in ovarian and breast cancer risk: a haplotype-based analysis.
Pearce CL; Hirschhorn JN; Wu AH; Burtt NP; Stram DO; Young S; Kolonel LN; Henderson BE; Altshuler D; Pike MC
J Natl Cancer Inst; 2005 Jan; 97(1):51-9. PubMed ID: 15632380
[TBL] [Abstract][Full Text] [Related]
3. Progesterone receptor gene variants and risk of endometrial cancer.
O'Mara TA; Fahey P; Ferguson K; Marquart L; Lambrechts D; Despierre E; Vergote I; Amant F; Hall P; Liu J; Czene K; ; Rebbeck TR; ; ; ; Ahmed S; Dunning AM; Gregory CS; Shah M; ; Webb PM; Spurdle AB
Carcinogenesis; 2011 Mar; 32(3):331-5. PubMed ID: 21148628
[TBL] [Abstract][Full Text] [Related]
4. Association of the progesterone receptor gene with endometrial cancer risk in a Chinese population.
Xu WH; Long JR; Zheng W; Ruan ZX; Cai Q; Cheng JR; Xiang YB; Shu XO
Cancer; 2009 Jun; 115(12):2693-700. PubMed ID: 19382201
[TBL] [Abstract][Full Text] [Related]
5. Progesterone receptor PROGINS and +331G/A polymorphisms confer susceptibility to ovarian cancer: a meta-analysis based on 17 studies.
Liu T; Chen L; Sun X; Wang Y; Li S; Yin X; Wang X; Ding C; Li H; Di W
Tumour Biol; 2014 Mar; 35(3):2427-36. PubMed ID: 24197980
[TBL] [Abstract][Full Text] [Related]
6. Common genetic variation in IGF1 and prostate cancer risk in the Multiethnic Cohort.
Cheng I; Stram DO; Penney KL; Pike M; Le Marchand L; Kolonel LN; Hirschhorn J; Altshuler D; Henderson BE; Freedman ML
J Natl Cancer Inst; 2006 Jan; 98(2):123-34. PubMed ID: 16418515
[TBL] [Abstract][Full Text] [Related]
7. Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the Ovarian Cancer Association Consortium pooled analysis.
Pearce CL; Wu AH; Gayther SA; Bale AE; ; Beck PA; Beesley J; Chanock S; Cramer DW; DiCioccio R; Edwards R; Fredericksen ZS; Garcia-Closas M; Goode EL; Green AC; Hartmann LC; Hogdall E; Kjaer SK; Lissowska J; McGuire V; Modugno F; Moysich K; Ness RB; Ramus SJ; Risch HA; Sellers TA; Song H; Stram DO; Terry KL; Webb PM; Whiteman DC; Whittemore AS; Zheng W; Pharoah PD; Chenevix-Trench G; Pike MC; Schildkraut J; Berchuck A;
Br J Cancer; 2008 Jan; 98(2):282-8. PubMed ID: 18219286
[TBL] [Abstract][Full Text] [Related]
8. Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk.
Painter JN; O'Mara TA; Batra J; Cheng T; Lose FA; Dennis J; Michailidou K; Tyrer JP; Ahmed S; Ferguson K; Healey CS; Kaufmann S; Hillman KM; Walpole C; Moya L; Pollock P; Jones A; Howarth K; Martin L; Gorman M; Hodgson S; ; ; De Polanco MM; Sans M; Carracedo A; Castellvi-Bel S; Rojas-Martinez A; Santos E; Teixeira MR; Carvajal-Carmona L; Shu XO; Long J; Zheng W; Xiang YB; ; Montgomery GW; Webb PM; Scott RJ; McEvoy M; Attia J; Holliday E; Martin NG; Nyholt DR; Henders AK; Fasching PA; Hein A; Beckmann MW; Renner SP; Dörk T; Hillemanns P; Dürst M; Runnebaum I; Lambrechts D; Coenegrachts L; Schrauwen S; Amant F; Winterhoff B; Dowdy SC; Goode EL; Teoman A; Salvesen HB; Trovik J; Njolstad TS; Werner HM; Ashton K; Proietto T; Otton G; Tzortzatos G; Mints M; Tham E; ; Hall P; Czene K; Liu J; Li J; Hopper JL; Southey MC; ; Ekici AB; Ruebner M; Johnson N; Peto J; Burwinkel B; Marme F; Brenner H; Dieffenbach AK; Meindl A; Brauch H; ; Lindblom A; Depreeuw J; Moisse M; Chang-Claude J; Rudolph A; Couch FJ; Olson JE; Giles GG; Bruinsma F; Cunningham JM; Fridley BL; Børresen-Dale AL; Kristensen VN; Cox A; Swerdlow AJ; Orr N; Bolla MK; Wang Q; Weber RP; Chen Z; Shah M; French JD; Pharoah PD; Dunning AM; Tomlinson I; Easton DF; Edwards SL; Thompson DJ; Spurdle AB
Hum Mol Genet; 2015 Mar; 24(5):1478-92. PubMed ID: 25378557
[TBL] [Abstract][Full Text] [Related]
9. Haplotype-based association studies of IGFBP1 and IGFBP3 with prostate and breast cancer risk: the multiethnic cohort.
Cheng I; Penney KL; Stram DO; Le Marchand L; Giorgi E; Haiman CA; Kolonel LN; Pike M; Hirschhorn J; Henderson BE; Freedman ML
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1993-7. PubMed ID: 17035411
[TBL] [Abstract][Full Text] [Related]
10. Genetic variation in the progesterone receptor gene and susceptibility to recurrent pregnancy loss: a case-control study.
Bahia W; Finan RR; Al-Mutawa M; Haddad A; Soua A; Janhani F; Mahjoub T; Almawi WY
BJOG; 2018 May; 125(6):729-735. PubMed ID: 28972310
[TBL] [Abstract][Full Text] [Related]
11. Genetic variation in CYP17 and endometrial cancer risk.
Gaudet MM; Lacey JV; Lissowska J; Peplonska B; Brinton LA; Chanock S; Garcia-Closas M
Hum Genet; 2008 Mar; 123(2):155-62. PubMed ID: 18172694
[TBL] [Abstract][Full Text] [Related]
12. Estrogen receptor polymorphisms and the risk of endometrial cancer.
Ashton KA; Proietto A; Otton G; Symonds I; McEvoy M; Attia J; Gilbert M; Hamann U; Scott RJ
BJOG; 2009 Jul; 116(8):1053-61. PubMed ID: 19438492
[TBL] [Abstract][Full Text] [Related]
13. Endometrial cancer and genetic variation in PTEN, PIK3CA, AKT1, MLH1, and MSH2 within a population-based case-control study.
Lacey JV; Yang H; Gaudet MM; Dunning A; Lissowska J; Sherman ME; Peplonska B; Brinton LA; Healey CS; Ahmed S; Pharoah P; Easton D; Chanock S; Garcia-Closas M
Gynecol Oncol; 2011 Feb; 120(2):167-73. PubMed ID: 21093899
[TBL] [Abstract][Full Text] [Related]
14. Progesterone Receptor (PGR) Gene Variants Associated with Breast Cancer and Associated Features: a Case-Control Study.
Ghali RM; Al-Mutawa MA; Ebrahim BH; Jrah HH; Zaied S; Bhiri H; Hmila F; Mahjoub T; Almawi WY
Pathol Oncol Res; 2020 Jan; 26(1):141-147. PubMed ID: 29302853
[TBL] [Abstract][Full Text] [Related]
15. Genetic variation in sex-steroid receptors and synthesizing enzymes and colorectal cancer risk in women.
Lin J; Zee RY; Liu KY; Zhang SM; Lee IM; Manson JE; Giovannucci E; Buring JE; Cook NR
Cancer Causes Control; 2010 Jun; 21(6):897-908. PubMed ID: 20148360
[TBL] [Abstract][Full Text] [Related]
16. Genetic variation in progesterone receptor gene and ovarian cancer risk: A case control study.
Kanabekova P; Al-Awadi AM; Bauyrzhanova Z; Tahtouh T; Sarray S; Almawi WY
Gene; 2022 Apr; 820():146288. PubMed ID: 35143942
[TBL] [Abstract][Full Text] [Related]
17. A comprehensive analysis of common genetic variation in prolactin (PRL) and PRL receptor (PRLR) genes in relation to plasma prolactin levels and breast cancer risk: the multiethnic cohort.
Lee SA; Haiman CA; Burtt NP; Pooler LC; Cheng I; Kolonel LN; Pike MC; Altshuler D; Hirschhorn JN; Henderson BE; Stram DO
BMC Med Genet; 2007 Dec; 8():72. PubMed ID: 18053149
[TBL] [Abstract][Full Text] [Related]
18. A comprehensive haplotype analysis of CYP19 and breast cancer risk: the Multiethnic Cohort.
Haiman CA; Stram DO; Pike MC; Kolonel LN; Burtt NP; Altshuler D; Hirschhorn J; Henderson BE
Hum Mol Genet; 2003 Oct; 12(20):2679-92. PubMed ID: 12944421
[TBL] [Abstract][Full Text] [Related]
19. Two estrogen-related variants in CYP19A1 and endometrial cancer risk: a pooled analysis in the Epidemiology of Endometrial Cancer Consortium.
Setiawan VW; Doherty JA; Shu XO; Akbari MR; Chen C; De Vivo I; Demichele A; Garcia-Closas M; Goodman MT; Haiman CA; Hankinson SE; Henderson BE; Horn-Ross PL; Lacey JV; Le Marchand L; Levine DA; Liang X; Lissowska J; Lurie G; McGrath M; Narod SA; Rebbeck TR; Ursin G; Weiss NS; Xiang YB; Yang HP; Zheng W; Olson SH
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):242-7. PubMed ID: 19124504
[TBL] [Abstract][Full Text] [Related]
20. Genetic variation in the progesterone receptor gene and ovarian cancer risk.
Terry KL; De Vivo I; Titus-Ernstoff L; Sluss PM; Cramer DW
Am J Epidemiol; 2005 Mar; 161(5):442-51. PubMed ID: 15718480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
